20120155

Ukraine. Pharma Market

Company overview

Partnering

1

2

3

historya)

activities

productse)

structureb)

c)

d) targeting

Pharma

Population

Territory

Trends

PIC/S

The pharmaceutical industry is a fast growing sector of the national economy. There are national pharmaceutical factories that produce medicines for local consumption. However the production doesn’t match market requirements.

The pharmaceutical industry is a fast growing sector of the national economy. There are national pharmaceutical factories that produce medicines for local consumption. However the production doesn’t match market requirements.

Ukraine. Country profile

In terms of population Ukraine is one of the largest countries in Europe. Ukraine has the population of about 46 million people. It is one of the biggest consumer markets in Europe.

In terms of population Ukraine is one of the largest countries in Europe. Ukraine has the population of about 46 million people. It is one of the biggest consumer markets in Europe.

Ukraine is the largest country in Europe in terms of territory. It covers a territory of 603,7 thousand square kilometers.Ukraine is the largest country in Europe in terms of territory. It covers a territory of 603,7 thousand square kilometers.

Ukraine has a bilateral relationships with many countries all over the world. Despite getting its independence only less than 20 years ago, it is emerging as a major player in trade and industry in Eastern Europe. Its pharmaceutical industry is in need of help at the moment and makes it a good time for foreign pharmaceutical companies to step in.

Ukraine has a bilateral relationships with many countries all over the world. Despite getting its independence only less than 20 years ago, it is emerging as a major player in trade and industry in Eastern Europe. Its pharmaceutical industry is in need of help at the moment and makes it a good time for foreign pharmaceutical companies to step in.

PIC/S (Pharmaceutical inspection Co-operation Scheme, 44 members all over the world) – Ukraine became the member of PIC/S on the 8th of November 2010. It is the 1st country among countries of CIS (Former Soviet Republics).

PIC/S (Pharmaceutical inspection Co-operation Scheme, 44 members all over the world) – Ukraine became the member of PIC/S on the 8th of November 2010. It is the 1st country among countries of CIS (Former Soviet Republics).

The Ukrainian retail pharmaceutical market is one of the fastest growing markets in Europe, growth

fueled by increase in average price per pack

The Ukrainian retail pharmaceutical market is one of the fastest growing markets in Europe, growth

fueled by increase in average price per packThe lowest per capita

medicine consumption among CEE

countries, development of

medical insurance and possible introduction

of reimbursement system evidence high growth potential of the market after economy

recovers.

The lowest per capita medicine consumption

among CEE countries,

development of medical insurance and possible introduction

of reimbursement system evidence high growth potential of the market after economy

recovers.

Hospital segment has not so good

dynamic due to problems with state financing

Hospital segment has not so good

dynamic due to problems with state financing

Market is dominated by

foreign companies in

value

(75% in 2013)

Market is dominated by

foreign companies in

value

(75% in 2013)

Total Market CAGR is more

than 14%

Total Market CAGR is more

than 14%

Till 2014 VAT for drugs was free, now it is 7%.

VAT for maedical devices is 20%.

Till 2014 VAT for drugs was free, now it is 7%.

VAT for maedical devices is 20%.

Domestic producers

traditionally focus on cheap mass

products

Domestic producers

traditionally focus on cheap mass

products

Retail and Hospital. Features

Dynamics (Dynamics (20201212 – 201 – 2014)4)

Values (bln, Units)Values (bln, Units)

Dynamics (Dynamics (20201212 – 201 – 2014)4)

Values (bln, Units)Values (bln, Units)

Hospital Retail

1,29

2013

1,39

0,66

1,4

0,21

2012

Pharma market

2014

1,39

0,68

1,28

Hospital Retail

2013

1,39

0,66

3,3

Dynamics (Dynamics (2020112 – 20142 – 2014))

Values (bln, USD)Values (bln, USD)

Pharma market

2012

1,4

0,47

3,9

2014

1,39

0,46

2,9

12563 medicines and medicines and

APIAPI

1476 positions of positions of

Biologically self Biologically self nutritionnutrition

5864 positions of Medical positions of Medical

devices and Personal devices and Personal products care products care

RegisteredRegistered20120144

Pharma market

Company overview

History

Add your title in here1994 1994

2000 2000

2001 2001

Foundation jointly with Heinrich Mack Nachf. GmbH& Co.KG (Pfizer Group)

Distribution Distribution

Registration of “ALEXPHARM GMBH LTD”Great Britain, London

Registration of “ALEXPHARM GMBH LTD”Great Britain, London

Combined marketing Combined marketing

Registration of “Alex Pharm Ltd”Ukraine, Kiev Registration of “Alex Pharm Ltd”Ukraine, Kiev

Functional marketingPromotion

Registration

Functional marketingPromotion

Registration

Structure

General managerGeneral manager

Field force departmentField force department

Marketing & PR department

Marketing & PR department

Product department

Product department

Registration departmentRegistration department

Medical representatives (30 persons)

Medical representatives (30 persons)

PromotionPromotion Sales pushingSales pushing

Coverage: 100%Coverage: 100%

Clinical trialsClinical trialsPromotion of the Promotion of the products in the products in the

marketmarket

RegistrationRegistrationMarketing Marketing researchesresearches

Activities

Product Product launch launch

activitiesactivities

Close cooperationClose cooperation with distributorswith distributors

Launch activities (promotion)

Pre – launch of the productPre – launch of the productPre – launch of the productPre – launch of the product

Medical publicationsMedical publications

Thought opinion leadersThought opinion leaders

Scientific meetings, conferencesScientific meetings, conferences

TrainingsTrainings Master classesMaster classes

Launch activities (promotion)

Launch and Post - launch of the productLaunch and Post - launch of the productLaunch and Post - launch of the productLaunch and Post - launch of the product

Field force detailing and samplingField force detailing and sampling

Launch activities (promotion)

Launch and Post - launch of the productLaunch and Post - launch of the productLaunch and Post - launch of the productLaunch and Post - launch of the product

Advertising on transportAdvertising on transport

Outdoor advertisingOutdoor advertising

Launch activities (promotion)

Ads Ads on TVon TVAds Ads

on TVon TV

Launch activities (promotion)

Launch and Post - launch of the productLaunch and Post - launch of the productLaunch and Post - launch of the productLaunch and Post - launch of the product

Marketing materials (creating, design, distribution) Marketing materials (creating, design, distribution)

Targeting

Target groupsTarget groups

Gynecology

Urology

Surgery

Therapy Cardiology

Dermato-venerology

Gastro-enterology

Immunology

Cosmetology

Products

“Collomak®” is a product №1 in group of keratolytics

in Ukraine.It was launched in the

market over 15 years ago.This product was twice the winner in the nomination

“Product of the year” in its ATC group

(“October Pharma S.A.E.”, Egypt under license of

Pfizer)

“Collomak®” is a product №1 in group of keratolytics

in Ukraine.It was launched in the

market over 15 years ago.This product was twice the winner in the nomination

“Product of the year” in its ATC group

(“October Pharma S.A.E.”, Egypt under license of

Pfizer)

Products

“Collost®” is an innovative bioplast sterile collagen material. It is used in cosmetology, stomatology, surgery(“BioPHARMAHOLDING”, Russia & Italy)

“Kagocel®”is an immunomodulator of natural origin (“Nearmedic Plus”, Russia).

“Kagocel®”is an immunomodulator of natural origin (“Nearmedic Plus”, Russia).

““Antaxone®”Antaxone®” INN Naltrexone

hydrochloride. A competitive

antagonist of opioid receptors.

““Faspic®”Faspic®”INN Ibuprofen+

L-arginin

““Fluimuci®”Fluimuci®”INN

Acetylcestyine

““Rinofluimucil®”Rinofluimucil®”Nazal spray

““Monural®”Monural®”(INN Fosfomycin

trometamol). Antibacterial for

cystitis treatment.

Products

Products

“Zithrolex®”

INN Azithromycin. Antibacterial agents for systemic use. Macrolides and linkozamids steptohramine (“October Pharma S.A.E.”, Egypt under license of PfizerPfizer)

)

“Zithrolex®”

INN Azithromycin. Antibacterial agents for systemic use. Macrolides and linkozamids steptohramine (“October Pharma S.A.E.”, Egypt under license of PfizerPfizer)

)

Products

Dietary supplement “Floranorm” capsulesTo normalize the intestinal microflora, particularly during and after antibiotics , with the threat of dysbiosis and intestinal dysbiosis, to restore intestinal flora with diarrhea and colitis. Improves immunity.Content of one package: (2×109) acidophilus SD5212, Lactobacillus delbrueckii ssp. Bulgaricus DSM15956, Bifidobacterium Lactis DSM15954, Streptococcus thernophilus SD 5207)

Manufactured by: Іncos Cosmeceutica Industriale S.r.L., Italy 

Partnering

Our partners:Our partners:Our partners:Our partners:

Novartis (Switzerland)

• Heinrich Mack Nachf. GmbH & Co.KG (Pfizer Group)

• Madaus AG (Germany)

• Zambon (Italy)

• TAD Pharma GmbH (Germany)

• Rivopharm (Switzerland)

• BioPHARMHOLDING (Russia, Italy)

Schering AG (Germany)

• CTC BIO (Korea), Іncos Cosmeceutica Industriale, Italy

Our officeOur office

Thank you for attention!Thank you for attention!

KievKiev